AIP
FTXH icon

Ameritas Investment Partners’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History

Ameritas Investment Partners’s Portfolio FTXH Stock Details FTXH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.3M Buy
33,987
+3,922
+13% +$137K 0.03% 547
2026
Q1 		$1.03M Buy
30,065
+11,967
+66% +$409K 0.03% 590
2025
Q4 		$596K Buy
18,098
+866
+5% +$27K 0.02% 784
2025
Q3 		$491K Buy
17,232
+1,521
+10% +$41.4K 0.02% 827
2025
Q2 		$403K Buy
15,711
+391
+3% +$9.9K 0.01% 934
2025
Q1 		$421K Buy
15,320
+1,147
+8% +$31.8K 0.01% 895
2024
Q4 		$382K Buy
14,173
+1,633
+13% +$45.8K 0.01% 956
2024
Q3 		$362K Buy
12,540
+500
+4% +$14.3K 0.01% 975
2024
Q2 		$328K Buy
12,040
+840
+8% +$22.5K 0.01% 971
2024
Q1 		$314K Buy
11,200
+587
+6% +$16.2K 0.01% 1008
2023
Q4 		$282K Buy
10,613
+56
+0.5% +$1.41K 0.01% 1066
2023
Q3 		$270K Sell
10,557
-90
-0.8% -$2.38K 0.01% 1004
2023
Q2 		$279K Sell
10,647
-41
-0.4% -$1.08K 0.01% 954
2023
Q1 		$279K Buy
10,688
+58
+0.5% +$1.55K 0.01% 929
2022
Q4 		$292K Buy
10,630
+791
+8% +$21K 0.01% 939
2022
Q3 		$236K Buy
+9,839
New +$254K 0.01% 983

Other funds holding FTXH

LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
OC
Oppenheimer & Co New York $9.37B AUM 36.4% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
MIM
Marshall Investment Management Littleton, Colorado $241M AUM 30.53% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
NP
Nilsine Partners Greenwood Village, Colorado $1.45B AUM 47.06% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Ameritas Investment Partners's FTXH Position: Q2 2026 in Review

Ameritas Investment Partners increased its First Trust Nasdaq Pharmaceuticals ETF (FTXH) stake by 13% in Q2 2026, buying an estimated $137K and bringing the position to 33,987 shares worth $1.3M. The position accounts for 0.03% of the portfolio, ranked #547.

Ameritas Investment Partners first reported a position in FTXH in Q3 2022 and has held it in 16 quarters since. 30 funds tracked by Wall St. Rank hold FTXH as of Q2 2026.

  • Ameritas Investment Partners held 33,987 shares of First Trust Nasdaq Pharmaceuticals ETF worth $1.3M as of Q2 2026.
  • Ameritas Investment Partners bought 3,922 First Trust Nasdaq Pharmaceuticals ETF shares in Q2 2026, an estimated $137K.
  • First Trust Nasdaq Pharmaceuticals ETF made up 0.03% of Ameritas Investment Partners's portfolio in Q2 2026, its #547 holding.
  • Ameritas Investment Partners first reported a position in First Trust Nasdaq Pharmaceuticals ETF in Q3 2022 and has held it in 16 quarters since.
  • 30 funds tracked by Wall St. Rank held First Trust Nasdaq Pharmaceuticals ETF as of Q2 2026.

Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.